Tagged: Drug Development

Bench-to-Budget: CPT Seeks Pharmacoepidemiology-Themed Research

July 31, 2024

Clinical Pharmacology & Therapeutics (CPT) has launched a Call for Papers for its April 2025 themed issue centering on pharmacoepidemiology, titled “Bench to Budget: Streamlining the Full Spectrum of Evidence Integration to Enhance Efficiency and Impact of Drug-Development and Patient Access.” Join host Alaina Webster as she welcomes CPT Editor-in-Chief Dr. Piet van der Graaf, Associate Editor Dr. Rebecca Miksad, and Guest Editor Dr. Sebastian Schneeweiss to discuss the relevance of this theme in today’s clin pharm landscape as well as what types of submissions they’d most like to receive. If you have questions about submitting for this pharmacoepidemiology-themed issue, please contact Deputy Managing Editor Alaina Webster at [email protected].

ASCPTPod

Bench-to-Budget: CPT Seeks Pharmacoepidemiology-Themed Research

00:00 / 13:41

PDUFA VI: It Is Time to Unleash the Full Potential of Model-Informed Drug Development with Drs. Lokesh Jain, Larissa Wenning, and Nitin Mehrotra from Merck

April 29, 2019

On this episode of PSPod, Drs. Lokesh Jain, Larissa Wenning, and Nitin Mehrotra from Merck discuss the important role model-informed drug development (MIDD) will play in the successful implementation of PDUFA VI. This discussion is based on their Perspective article “PDUFA VI: It’s Time to Unleash the Full Potential of Model-Informed Drug Development” which published in the January 2019 issue of PSP. The article is available here.

PSPod

PDUFA VI: It Is Time to Unleash the Full Potential of Model-Informed Drug Development with Drs. Lokesh Jain, Larissa Wenning, and Nitin Mehrotra from Merck

00:00 / 19:45

“Thoughtflow” with guests Mike Smith, Justin Wilkins, and Amy Cheung

November 10, 2017

On today’s episode, Mike Smith from Pfizer, Justin Wilkins from Occams, and Amy Cheung from AstraZeneca discuss “Thoughtflow”, a set of standards compiled by the DDMoRe consortium to help facilitate the capture, storage, and reporting of knowledge in the context of MID3, as well as to support reproducibility.

PSPod

"Thoughtflow" with guests Mike Smith, Justin Wilkins, and Amy Cheung

00:00 / 17:39

Good Practices in Model-Informed Drug Discovery and Development with guests Scott Marshall, Sandra Visser, and Amy Cheung

May 9, 2016

In this episode, Drs. Scott Marshall from Pfizer, Sandra Visser from Merck, and Amy Cheung from AstraZeneca discuss “Good Practices in Model-Informed Drug Discovery and Development: Practice, Application, and Documentation”: their White Paper published in the March 2016 issue of PSP. You can get free access the White Paper by clicking here.

Listen and subscribe for free on iTunes and Google Play

PSPod

Good Practices in Model-Informed Drug Discovery and Development with guests Scott Marshall, Sandra Visser, and Amy Cheung

00:00 / 27:30